Skip to content

A Team of Visionaries

We are scientists, engineers, cloud experts, and compliance specialists dedicated to accelerating genomic research to advance scientific discovery and deliver better patient care.

Executive Leadership Team

  • Thomas Laur

    Thomas Laur

    Chief Executive Officer

    Thomas Laur

    Chief Executive Officer
    Thomas brings over 25 years of international experience focused on driving growth and innovation for software, data and services companies in the healthcare and life sciences space. Prior to DNAnexus, Thomas was EVP and President at Change Healthcare (NASDAQ: CHNG). Before that, Thomas was President of the global health sciences division at SAP. Previously, Thomas was CEO of Sutherland Healthcare Solutions, and he also worked at Cognizant, as Managing Director responsible for a portfolio of healthcare ventures. Thomas started his career at Deloitte Consulting, where he focused on strategy, transformation, and merger & acquisition programs for technology companies. He received his Master in Business Management degree from the ICHEC Brussels Management School in Brussels, Belgium.
  • George Asimenos

    George Asimenos, PhD

    Chief Product Officer

    George Asimenos, PhD

    Chief Product Officer
    Part of DNAnexus since its inception, George has been involved in the design and implementation of the DNAnexus product line and its application in key accounts around the world. George holds a PhD in computer science from Stanford University, where he helped analyze 1% of the human genome as part of the ENCODE Pilot Project. His prior research experience includes comparative metagenomics, silicon compilers for reconfigurable hardware, and elliptic curve cryptanalysis.
  • Jim-McNicholas

    James McNicholas

    Chief Financial Officer

    James McNicholas

    Chief Financial Officer
    Jim serves as our Chief Financial Officer. Most recently, he was the CFO for Cumulus Networks (sold to NVIDIA). Prior to Cumulus, he held CFO roles at Panasas, VSS Network Monitoring, Solexant Corp, and Nanosolar. He entered the venture capital world after serving as the VP of Finance for 4 divisions of IBM (Hard Disk Drives, Storage Subsystems, Consumer Products Division, and Open System Servers & Software) as well as Hitachi Global Storage Technologies. Jim received a BS in Commerce & Engineering from Drexel University and an MBA from Stanford.
  • Kelly Green

    Kelly Green

    Chief People Officer

    Kelly Green

    Chief People Officer
    Kelly leads efforts in all things "people”. She is responsible for talent acquisition, employee growth and development, building a great culture, and facilitating organizational development. Kelly joined DNAnexus after leading HR at Telenav, another disruptive tech company in Silicon Valley. There, Kelly led the HR transition from venture-backed “start up” through a successful IPO. She holds a Bachelor's in Psychology from Stonehill College.
  • Bill Madigan

    Bill Madigan

    Chief Commercial Officer

    Bill Madigan

    Chief Commercial Officer

    Bill Madigan is a tech-savvy leader firmly committed to entrepreneurship, innovation, and disrupting traditional healthcare markets.. With over 25 years of commercial and business leadership, Bill’s expertise spans all key healthcare sectors including Life Sciences, Payers and Providers.  Prior to joining DNAnexus, Bill served as Chief Revenue Officer (CRO) of  Komodo Health.  Prior to Komodo, Bill worked in leadership positions across UHG’s Optum as a Senior Director of Sales for Optum’s Life Sciences division and the US Head of Provider Analytics.  Bill obtained his Masters of Business Administration (MBA) from Northeastern University in Boston, MA.

  • Omar Serang

    Omar Serang

    EVP & GM, Regulatory & Government Solutions

    Omar Serang

    EVP & GM, Regulatory & Government Solutions
    Omar has decades of experience designing global cloud platforms pioneering the use of collaborative feedback networks to solve challenging information extraction problems. He is the Principal Architect of precisionFDA.gov, the FDA cloud platform that is transforming the regulatory research and review process for precision drugs and devices. Prior to DNAnexus, Omar managed operations for the AWS Elastic Compute Cloud when single regions were topping the one-million server mark. Previously, he led platforms for a Twitter search engine at Topsy Labs, and crowd-sourced messaging security at Cloudmark. Omar received his Bachelor of Science in Chemistry from UC Berkeley.
  • Jeff Keller, PhD

    Jeff Keller, PhD

    EVP & GM, Health Systems & Biobanks

    Jeff Keller, PhD

    EVP & GM, Health Systems & Biobanks
    Jeff Keller has worked in biomedical research, business and the development of early stage technologies. He has a doctorate in cell and developmental biology from Vanderbilt University and performed post-doctorate research at Massachusetts Institute of Technology’s David H. Koch Center for Integrative Cancer Research.
  • Todd Oakland, PhD

    Todd Oakland, PhD

    SVP & GM, Pharma & Diagnostics

    Todd Oakland, PhD

    SVP & GM, Pharma & Diagnostics
    Todd Oakland serves as our Senior Vice President and General Manager, Biopharma Rx/Dx. Prior to joining DNAnexus, he was Vice President and Product Lead for Precision Oncology at ConcertAI, where he led real-world data strategy and product development across pharmaceutical and diagnostics partnerships.

    Before ConcertAI, Todd held multiple roles at Aitia, including Vice President of Customer Success and Executive Director of Real-World Evidence and Analytics, helping to advance the company’s causal AI platform for life sciences applications. He also spent time at Optum leading engagements on the RWE team, focusing on pharmaceutical clients with large-scale healthcare data and analytics.

    Todd began his career in translational science and academia, with roles at the University of Chicago and Harvard T.H. Chan School of Public Health. He holds a Ph.D. in Virology from the University of Chicago, an M.P.H. in Quantitative Methods from the Harvard T.H. Chan School of Public Health, and a B.S. in Molecular Biology from Purdue University.

Senior Management Team

  • Kushtrim Kuqi, PhD

    Kushtrim Kuqi, PhD

    SVP, Product & AI

    Kushtrim Kuqi, PhD

    SVP, Product & AI
    Kushtrim leads product and AI at DNAnexus, overseeing the platform roadmap and the company's AI initiatives. He has 19+ years of experience building enterprise data platforms and AI-powered products at companies including CertifyOS, 1upHealth, Clearcover, RallyHealth, and M*Modal. Kushtrim holds a PhD in Systems Engineering from George Washington University and a degree in AI for Business from the University of Oxford.
  • Mia Nease

    Mia Nease

    SVP, US Sales

    Mia Nease

    SVP, US Sales
    As Senior Vice President at DNAnexus, Mia Nease is at the forefront of transforming healthcare through data-driven science. She oversees Sales for the Americas region, ensuring that researchers and clinicians across the continent have the secure, scalable infrastructure needed to advance precision health.

    A champion for innovation in the genomics ecosystem, Mia brings deep expertise in navigating complex healthcare markets and scaling cutting-edge technology platforms. Prior to joining DNAnexus, she honed her leadership in biomedical data and healthcare strategy through impactful roles with the Institute for Systems Biology and PwC Advisory for Life Sciences.

    Mia holds a Doctorate in Business, with a specialized research focus on the implementation of innovation into complex care settings—a background that directly informs her approach to driving enterprise growth and adoption in the life sciences sector.
  • Arun Bhat

    Arun Bhat

    Head of Engineering

    Arun Bhat

    Head of Engineering
    Arun leads all of engineering for DNAnexus, which he joined in 2017 and has since been instrumental in building many of the company's product lines. He brings over 25 years of cloud and enterprise software experience to his role, having previously spent more than a decade in technical leadership positions at Model N, including serving as Chief Architect. Arun holds a BS in Computer Science from the Indian Institute of Technology Varanasi.
  • Kristy Cloyd-Warwick, PhD

    Kristy Cloyd-Warwick, PhD

    SVP, Customer Experience

    Kristy Cloyd-Warwick, PhD

    SVP, Customer Experience
    Kristy Cloyd-Warwick leads the Customer Experience organization at DNAnexus, ensuring that every customer achieves the scientific and clinical outcomes they expect. Reflecting DNAnexus’s investment in elite industry expertise, her organization spans Customer Success, DNAnexus Care (a 24/7 global scientific and technical support team), Technical Enablement, the DNAnexus Academy, and a world-class Professional Services division.

    An accomplished scientific executive with over 15 years of experience scaling enterprise genomic and multi-omic data ecosystems, Kristy previously managed global bioinformatics and informatics organizations, including at QIAGEN. She holds a PhD in Biomedical Engineering and Biomaterials from Imperial College London, alongside a surgical device patent and multiple highly cited, peer-reviewed publications.
  • Andrew Slotnick

    Andrew Slotnick

    SVP, Marketing

    Andrew Slotnick

    SVP, Marketing
    Andrew leads marketing and communications for DNAnexus. He joined DNAnexus most recently from Biofourmis, having spend 20+ years in healthcare and technology at companies including CVS Health, GE Healthcare, and GSK. Andrew has an MBA in Marketing from Babson College.
  • Keith McCartney

    Keith McCartney

    SVP, Security & IT

    Keith McCartney

    SVP, Security & IT
    Keith McCartney leads the Security and Technology (IT) functions at DNAnexus, bringing over 20 years of experience building and scaling security programs across enterprise organizations. He previously built security programs at Zenefits, Informatica, and Zurich Insurance Group, and holds a degree in Electrical Engineering from the University of Florida.
  • Jimita Parekh

    Jimita Parekh

    VP, Regulatory Technology & Innovation

    Jimita Parekh

    VP, Regulatory Technology & Innovation
    Jimita Parekh leads strategy and innovation for Regulatory Solutions at DNAnexus, partnering with health authorities and pharmaceutical companies on innovations that accelerate therapies to patients through faster, more collaborative regulatory pathways. She drives DNAnexus' Trusted Regulatory Spaces (TRS) vision and oversees the agency engagements like the FDA's FedRAMP Authorized precisionFDA platform for PRISM. Jimita brings more than 20 years of experience in regulatory technology and clinical data across global biopharma, including senior roles at Genentech and Medable, and serves as an expert advisor to the European Medicines Agency. A pharmacist by training, she holds a B.Pharm from MET School of Pharmacy in Mumbai and has pursued executive programs at Berkeley Haas School of Business in AI Business Strategies.
  • Daniel Schneider

    Daniel Schneider

    VP, Legal

    Daniel Schneider

    VP, Legal
    Daniel leads legal and privacy for DNAnexus, providing strategic legal leadership for the company’s high-growth SaaS platform in precision medicine and genomics. He brings extensive experience from a range of in-house legal roles in life sciences and tech companies. His primary focus is negotiating complex commercial agreements—including licensing terms, data usage rights, and service-level agreements—with pharmaceutical and biotechnology clients.
  • Meredith Schwenk

    Meredith Schwenk

    VP, Enterprise Communications & Public Affairs

    Meredith Schwenk

    VP, Enterprise Communications & Public Affairs

    Meredith is a corporate communications executive with more than two decades of experience stewarding enterprise reputation and defining corporate narrative. Her multifaceted expertise encompasses public affairs, internal communications, brand strategy, and crisis management. Prior to her role at DNAnexus, Meredith held communications leadership positions for a diverse portfolio of established brands, including Rue Gilt Groupe, J.Jill, Staples, Bose, and Care.com. She holds a BA in Mass Communication with a minor in Women’s Studies from the University of Delaware.

  • Sarah Yang

    Sarah Yang

    VP, Professional Services

    Sarah Yang

    VP, Professional Services
    Sarah leads the Professional Services organization at DNAnexus. She brings over 15 years of expertise in consulting and healthcare technology, with previous experience including roles at Deloitte, the National Institutes of Health (NIH), and Children’s National Medical Center. Sarah holds a degree in biology from the University of Maryland and studied computer science at Johns Hopkins University.
  • Kah H Liew

    Kah H Liew

    VP, Accounting & Finance

    Kah H Liew

    VP, Accounting & Finance
    Kah leads finance and accounting at DNAnexus, bringing over 16 years of experience in the semiconductor, software, and biotechnology sectors. Prior to DNAnexus, he held finance leadership roles at Ultima Genomics and spent 12 years at PwC, where he worked closely with various Fortune 50 technology companies. Kah is a CPA and holds an MBA from the Wharton School of the University of Pennsylvania.
  • imani tate

    Imani Tate

    VP, Corporate Governance, Risk, & Compliance

    Imani Tate

    VP, Corporate Governance, Risk, & Compliance
    Imani is a leader in Governance, Risk, and Compliance, with a track record in building and scaling regulatory and compliance programs within rapid-growth SaaS environments. Prior to DNAnexus, Imani served as Director of Governance, Risk, and Compliance at MongoDB, where she shaped global compliance and risk strategy across public sector and commercial SaaS offerings. Imani brings experience leading compliance initiatives at scale within Google’s global cloud compliance team and providing advisory and support for software companies and federal agencies in roles at KPMG and IBM Global Business Services. Imani received her BS in Science, Technology, and International Affairs from Georgetown University.

Board of Directors

  • Michael Goldberg

    Michael Goldberg

    Executive Chair, Board of Directors

    Michael Goldberg

    Executive Chair, Board of Directors
    Michael Goldberg has enabled pioneering companies that have advanced patient care in cardiology, oncology , and immunology based on genomics and related areas of digital technology for more than three decades. He has experience as a company founder, CEO, and Silicon Valley-based venture capitalist focused on biotechnology .

    Michael has been an investor and board member of numerous venture backed life science companies including:
    • Executive Chair, Board of Directors of DNAnexus (genomics in the cloud),
    • Chair, Board of Directors CareDx - NASDAQ:CDNA (Genomic tests for organ transplant patients)
    • Founding Investor, Chair/Member, Board of Directors iRhythm - NASDAQ:IRTC (wearable cardiovascular devices),
    • Chair, Board of Directors of YorUltrasound ( AI driven , wireless handheld ultrasound),
    • Lead Director / Member, Board of Directors eHealth, Inc– NASDAQ: EHTH (pioneer in online consumer driven healthcare)

    He is a former board member of the Western Association of Venture Capitalists and of numerous non-profit and university advisory boards including:
    • Harvard Center of Genetics and Genomics,
    • Berkeley Center for Law and Technology,
    • Caltech Division of Biology,
    • Stanford Distinguished Career Institute.

    He is a graduate of Brandeis University and the Stanford Graduate School of Business.
  • Mike Kirkman

    Mike Kirkman

    Board Member

    Mike Kirkman

    Board Member
    Mike Kirkman is a Managing Director in Blackstone Growth (BXG) where he is focused on investments in the Healthcare sector. Mr. Kirkman is based in San Francisco.

    Before joining Blackstone, Mr. Kirkman was a Director at GI Partners where he helped lead investment activity in the healthcare and software sectors. During his time at GI, he invested in and served on the boards of such companies as Netsmart, Generate Life Sciences, Clinical Ink, and MRI Software. Prior to GI, Mr. Kirkman was with JLL Partners in New York, where he began his investing career, focusing on private equity investments in North America. Mr. Kirkman currently serves on the board of the San Francisco Private Equity Network.

    Mr. Kirkman holds a BS from the McIntire School of Commerce at the University of Virginia and an MBA from the Wharton School of the University of Pennsylvania.
  • Thomas Laur headshot (2)

    Thomas Laur

    CEO, Board Member

    Thomas Laur

    CEO, Board Member
    Thomas brings over 25 years of international experience focused on driving growth and innovation for software, data and services companies in the healthcare and life sciences space. Prior to leading DNAnexus, Thomas was EVP and President at Change Healthcare (NASDAQ: CHNG). Before that, Thomas was working for SAP, where he was President of the global health sciences division. Previously, Thomas was CEO of Sutherland Healthcare Solutions, and he also worked at Cognizant, as Managing Director responsible for a portfolio of healthcare ventures. Thomas started his career at Deloitte Consulting, where he focused on strategy, transformation, and merger & acquisition programs for technology companies. He received his Master in Business Management degree from the ICHEC Brussels Management School in Brussels, Belgium.
  • Jeffrey Margolis

    Jeffrey Margolis

    Board Member

    Jeffrey Margolis

    Board Member
    Mr. Margolis’ extensive industry experience includes 20 years as the CEO and/or chairman and another decade as a chief information and technology officer at publicly traded and private healthcare technology companies. He most recently served as the Chairman and CEO at Welltok, Inc., where he led the company from a pre-revenue startup to a leading enterprise consumer activation company. Before joining Welltok, Inc., Mr. Margolis founded and spent 14 years as CEO and Chairman of TriZetto Corporation, the first vertical SaaS enterprise software company.

    Mr. Margolis currently serves as Chairman at NextGen Healthcare (NASDAQ:NXGN), Vice Chairman at TriNetX, and as a board member at Alignment Healthcare (NASDAQ: ALHC), Hydrogen Health, and Grin. He serves as Chairman for the Hoag Clinic and the University of California at Irvine’s Center for Digital Transformation. Mr. Margolis is a leadership fellow with the National Association of Corporate Directors and a member of the American Institute of Certified Public Accountants with a Certified Global Management Accountant designation. He holds a bachelor of science degree with high honors in business administration–management information systems from the University of Illinois at Urbana-Champaign.
  • Andrea Jackson

    Andrea Jackson

    Board Member

    Andrea Jackson

    Board Member
    Andrea Jackson is a Partner at Northpond Ventures. She joined Northpond in 2020 after 12 years of operating and finance roles in small and large scientific and technology companies. Andrea’s work at Northpond focuses on leading the people operations and portfolio management of the investment team. She serves on multiple Boards for the fund. Andrea received an MBA from Kellogg School of Management at Northwestern University and a B.A. with honors from Washington University in St. Louis.
  • Ralph Snyderman, MD

    Ralph Snyderman, MD

    Board Member

    Ralph Snyderman, MD

    Board Member
    Dr. Snyderman served as Chancellor for Health Affairs and Dean of the School of Medicine at Duke University from 1989 to July 2004.  During this time, he oversaw the development of the Duke University Health System and served as its first president and CEO.  Dr. Snyderman’s current focus is personalized health care and he continues to lead these efforts nationally from his position as Director of the Duke Center for Personalized Health Care.

    Areas of expertise and national recognition: Personalized Health Care,  Immunology, Inflammation, Rheumatology and Medical Center Administration.